COMMUNIQUÉS West-GlobeNewswire

New Health Economic Evidence Shows Health & Cost Benefits When Starting Dialysis at Home
05/06/2026
New UK economic analyses show improved patient outcomes and health system savings – including nearly £200 million in projected UK NHS savings over 5 years – through increased uptake of home-based peritoneal dialysis [...]
Fangzhou Showcases AI-Powered Chronic Disease Management Solution With Tencent Health at Tencent Cloud Conference
05/06/2026
BEIJING, June 05, 2026 (GLOBE NEWSWIRE) -- Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leading provider of AI‑driven Internet healthcare solutions, attended the 2026 Tencent Cloud AI Industry [...]
Chiesi Global Rare Diseases Announces European Commission Approval of LOJUXTA® (lomitapide) ▼ Capsules for Paediatric Use in Homozygous Familial Hypercholesterolaemia (HoFH)
05/06/2026
European Commission approval expands the indication of lomitapide in the European Union (EU) to include children 5 years of age and older with HoFH, an ultra-rare genetic disorder affecting LDL-cholesterol levels PARMA [...]
Research Peptides: Koi Research Labs Expands Distribution Across USA & Canada
05/06/2026
NEW YORK, NY, June 05, 2026 (GLOBE NEWSWIRE) -- Koi Research Labs today announced the expansion of its research-grade peptide distribution across the United States and Canada, giving qualified researchers in both [...]
Phase IIb Study Results of InnoCare’s Orelabrutinib in Patients with SLE Presented at 2026 EULAR
05/06/2026
BEIJING, June 05, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that study results [...]
Addex Convenes Annual General Meeting 2026
05/06/2026
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, June 5, 2026 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small [...]
Iron Age Nutrition Announces Launch of “Sour Apple Crush” Flavor in Total Hydrate Electrolyte Line
05/06/2026
FORT LAUDERDALE, FL, June 04, 2026 (GLOBE NEWSWIRE) -- Iron Age Nutrition announced the introduction of “Sour Apple Crush,” a new flavor within its Total Hydrate electrolyte line. The addition expands the company’s [...]
Native Life Appoints FIFA Brand Designer Jody Ure to Lead Creative Strategy and Support National Expansion
05/06/2026
Miami, Florida, June 04, 2026 (GLOBE NEWSWIRE) -- Native Life, an emerging life and health insurance company operating across all 50 states, announced the appointment of globally recognized FIFA brand designer Jody Ure [...]
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
04/06/2026
NEW YORK, June 04, 2026 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that on June 1, 2026, the Company [...]
Nyxoah Entre dans une Nouvelle Phase de Création de Valeur à Long Terme
04/06/2026
INFORMATIONS PRIVILÉGIÉES INFORMATIONS RÉGLEMENTÉES Nyxoah Entre dans une Nouvelle Phase de Création de Valeur à Long Terme Lancement du processus de transition vers un Chief Executive Officer basé aux États-Unis Cette [...]
BIO GREEN MED SOLUTION, INC. ANNOUNCES BUSINESS COMBINATION AGREEMENT TO ACQUIRE FUTURE NRG SDN. BHD.
04/06/2026
Creation of a next-generation environmental platform: The proposed transaction brings together essential safety and environmental services, with a strategic focus on regulatory-driven industries where compliance, [...]
Lyell Immunopharma to Present Phase 1/2 Safety and Translational Data for Ronde-Cel in Large B-Cell Lymphoma at the European Hematology Association 2026 Congress
04/06/2026
SOUTH SAN FRANCISCO, Calif., June 04, 2026 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a late-stage clinical company advancing a pipeline of next-generation chimeric antigen receptor (CAR) T-cell [...]
GILEAD SCIENCES AND LAKEFRONT COMPLETE ACQUISITION OF OURO MEDICINES TO FURTHER EXPAND INFLAMMATION PIPELINE
04/06/2026
Companies will collaborate on the development of gamgertamig, a potential first-in-class and best-in-class T cell engager in autoimmune diseases Foster City, Calif. and Mechelen, Belgium; June 4, 2026, 22.15 CET – [...]
Nyxoah Annonce une Proposition d'Offre d'Actions Ordinaires
04/06/2026
INFORMATIONS PRIVILÉGIÉES INFORMATIONS RÉGLEMENTÉES Nyxoah Annonce une Proposition d'Offre d'Actions Ordinaires Mont-Saint-Guibert, Belgique – 4 juin 2026, 22h02 CET / 16h02 ET – Nyxoah SA (Euronext Brussels/Nasdaq : [...]
Nyxoah Enters New Chapter of Long Term Value Creation
04/06/2026
INSIDE INFORMATION REGULATED INFORMATION Nyxoah Enters New Chapter of Long Term Value Creation Commencement of process to transition to a U.S.-based CEO Transition to support further acceleration of commercial Genio [...]
Praxis Precision Medicines to Participate in Goldmans Sachs 47th Annual Global Healthcare Conference
04/06/2026
BOSTON, June 04, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines , Inc. (NASDAQ: PRAX), a fully integrated, leading central nervous system (CNS) precision neuroscience biopharmaceutical company, today announced it [...]
Zhengye Biotechnology Holding Limited Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
04/06/2026
Jilin, China, June 04, 2026 (GLOBE NEWSWIRE) -- Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the “Company” or “Zhengye”), a veterinary vaccine manufacturer that encompasses research, development, manufacturing [...]
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
04/06/2026
CONSHOHOCKEN, Pa., June 04, 2026 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated [...]
SI-BONE To Present at Truist Securities 2026 MedTech Conference on June 16, 2026
04/06/2026
SANTA CLARA, Calif., June 04, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone, today announced [...]

Pages